Skip to Main Content

Paper Details

Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
J Alzheimers Dis
27
2017
APOE4, Alzheimer's disease, BChE, BChE-, BChE-K, BChE-K genotype, Butyrylcholinesterase, Butyrylcholinesterase K, Donepezil, K, MCI, Mild Cognitive Impairment, acetylcholine, acetylcholinesterase, butyrylcholinesterase, common allele, donepezil, mild cognitive impairment, patients, vitamin E
Author NameAffiliation
Xiaohui LiInstitute for Translational Genomics and Population Sciences and Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-university of california los angeles Medical Center
Xiaohui LiHarbor-university of california los angeles Medical Center
Kent D TaylorInstitute for Translational Genomics and Population Sciences and Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-university of california los angeles Medical Center
Kent D TaylorHarbor-university of california los angeles Medical Center
Jerome I RotterInstitute for Translational Genomics and Population Sciences and Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-university of california los angeles Medical Center
Jerome I RotterHarbor-university of california los angeles Medical Center
Paul S AisenAlzheimer's Therapeutic Research Institute, University of Southern California
Liana G ApostolovaIndiana University School of Medicine
  • 1 - 8

Datasets

Release 1.2